GGrantIndex
Sort

64,565 grants matching drug discovery

Engineering a Human Skeletal Muscle Tissue Model of LGMD2B

$501,861
Nenad Bursac · Duke University · R01 · FY2024 · AR

RESEARCH PROJECT 4: Biomarker-based Evaluation of Human Interventions

$501,844
Thomas A Kensler · Johns Hopkins University · P01 · FY2011 · ES

Learning Drug Specificity in Protein Families by Docking

$501,820
Biocomputing Group, Inc. · R44 · FY2003 · GM

SARS Receptor Characterization/Virus Binding Blockagage

$501,756
University Of Colorado Denver · P01 · FY2004 · AI

Training in Pharmacological Sciences

$501,750
Joey V Barnett · Vanderbilt University · T32 · FY2015 · GM

LATE TRANSITION METAL CATALYSTS FOR ORGANIC SYNTHESIS

$501,720
Massachusetts Institute Of Technology · R01 · FY2005 · GM

Admin-Core

$501,716
Prakash S. Nagarkatti · University Of South Carolina At Columbia · P30 · FY2024 · GM

Admin-Core

$501,716
Prakash S. Nagarkatti · University Of South Carolina At Columbia · P30 · FY2025 · GM

High throughput in vivo screening: translational generation of novel analgesics

$501,681
Richard A Houghten · Torrey Pines Inst For Molecular Studies · R01 · FY2012 · DA

Endocannabinoid Biosynthesis in Inflammation and Pain

$501,620
Ku-Lung Hsu · University Of Texas At Austin · R01 · FY2025 · DA

Molecular Analysis of Modular Polyketide Synthases

$501,609
David H Sherman · University Of Michigan At Ann Arbor · R01 · FY2014 · GM

Phenotyping novel organogenesis lethal KOMP alleles

$501,583
Kimberly D Tremblay · University Of Massachusetts Amherst · R01 · FY2019 · HD

'Chemical & Genetic Approaches to Defining & Validating Vulnerable Mycobact Targ

$501,541
Eric Joseph Rubin · Texas A&M University · P01 · FY2014 · AI

Mapping the Pharmacogenetic Landscape for Precision Medicine

$501,481
Alan Ashworth · University Of California, San Francisco · U54 · FY2021 · CA

Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology

$501,426
Timothy Patrick Spicer · Scripps Florida · R33 · FY2016 · CA

Synthetic cathinones: a new class of illicit drugs affecting DAT & SERT

$501,407
Louis J De Felice · Virginia Commonwealth University · R01 · FY2012 · DA

Symbiosis and Chemical Diversity Generation

$501,404
Eric W Schmidt · University Of Utah · R35 · FY2017 · GM

Intensive longitudinal study of suicidal behaviors and related health outcomes

$501,356
Matthew K Nock · Harvard University · U01 · FY2020 · MH

Develop BCL-xL proteolysis targeting chimeras as safer and better senolytics

$501,347
Guangrong Zheng · University Of Florida · R01 · FY2023 · AG

600 MHz NMR console and cold probe

$501,337
David Nigel Jones · University Of Colorado Denver · S10 · FY2018 · OD

Novel Hsp90 Inhibitors to Reduce Misfolded Proteins in Alzheimer's Disease

$501,311
Mary L. Michaelis · University Of Kansas Lawrence · U01 · FY2011 · AG

Pharmacoepidemiology and Pharmacogenetics of a Statin AE

$501,301
Bruce M Psaty · University Of Washington · R01 · FY2007 · HL

Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias

$501,273
Lisa M. Ellerby · Buck Institute For Research On Aging · P01 · FY2025 · AG

Optically Promoting Cardiac Maturation Using Engineered Peptides

$501,245
Herdeline Ann Mallari Ardoã‘a · University Of California-Irvine · R01 · FY2023 · HL

Understanding and Targeting Host Processes Essential to Plasmodium Infection

$501,236
Emily R Derbyshire · Duke University · R01 · FY2023 · AI